CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation of proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at Oppenheimer’s 19th Annual Healthcare Conference, at 1:20 p.m. EST on November 3, 2008, at the Waldorf-Astoria Hotel in New York, New York.
